Page 135 - Azerbaijan State University of Economics
P. 135

THE JOURNAL OF ECONOMIC SCIENCES: THEORY AND  PRACTICE, V.71,  # 1, 2014,  pp. 127-139



                     Overall 35 references and publication outcomes were integrated in the simulation model


               and connected according to  the  illustrated methodology in figure  2. For the  results of this

               simulation the original source data of the german simulation - where original data was missing –

               was interpolated: over source data context like cost of hospital days or where nothing else was


               available over the per capita spending Germany vs. AR [Implementing Health Sector Reform in

               Central Asia: Papers from a Health Policy Seminar Held in Ashgabat, Turkmenistan in June,

               1996  Zuzana Feachem, Martin Hensher, Laura Rose, World Bank Publications, 1999]. The main


               data used can be seen in table 1.

                      Description and Reference for financial data (selected work)            Value per
                                                                                                 Patient
                      Value for a quality-adjusted life (cost / QALY), mean, interpolated [H.   4.000 US$ p.
                      Dakin et al. „The influence of cost-effectiveness and other factors on     QALY
                      NICE decisions” in HERC Research Paper 05/14]
                      Cost for a day in a hospital (non-intensiv care), WHO [Data from the   37.38 US$ p.d.
                      WHO http://www.who.]
                      Cost for a day in a hospital (intensive care), rounded average WHO[Data   66.61 US$ p.d
                      from the WHO http://www.who.int/choice/country/aze/cost/en/]
                      Savings overCHF monitoring, interpolated from German simulation    416,63 US$ p.a.
                      [Kielblock, B., et al. "Einfluss einer telemedizinisch unterstützten
                      Betreuung auf Gesamtbehandlungskosten und Mortalität bei chronischer
                      Herzinsuffizienz." Dtsch Med Wochenschr 132.9 (2007): 417-22.]
                      Adverse events due to Anticoagulation [Hamby L, Weeks WB,           19.81 US$ p.a.
                      Malikowski C Complications of warfarin therapy: causes,costs, and the
                      role of the anticoagulation clinic. Eff Clin Pract . 2000;3:179–184]
                      Cost of a single “mean” stroke (lifetime costs, discounted) [Kolominsky-  3.667 US$ p.
                      Rabas, Peter L., et al. "Lifetime cost of ischemic stroke in germany:      Stroke
                      Results and national projections from a population-based stroke registry
                      the erlangen stroke project." Stroke 37.5 (2006): 1179-1183.]
                      Cost of a single “mean” myocardial infarction (MI) [Gandjour, A., F.   1.641 US$ p. MI
                      Kleinschmit, and K. W. Lauterbach. "European comparison of costs and
                      quality in the treatment of acute myocardial infarction (2000–
                      2001)."European heart journal 23.11 (2002): 858-868.]
                     Table 1: Used Cost Parameter








                                                           135
   130   131   132   133   134   135   136   137   138   139   140